Redx Pharma PLC (LON:REDX) insider Iain Ross acquired 348,000 shares of the company’s stock in a transaction that occurred on Tuesday, November 14th. The stock was purchased at an average cost of GBX 18 ($0.24) per share, with a total value of £62,640 ($82,388.53).
Redx Pharma PLC (LON REDX) opened at GBX 19 ($0.25) on Wednesday. Redx Pharma PLC has a 12 month low of GBX 17.10 ($0.22) and a 12 month high of GBX 48.25 ($0.63).
ILLEGAL ACTIVITY NOTICE: “Redx Pharma PLC (REDX) Insider Iain Ross Purchases 348,000 Shares” was published by Sports Perspectives and is the sole property of of Sports Perspectives. If you are viewing this report on another site, it was stolen and reposted in violation of US and international trademark and copyright legislation. The legal version of this report can be viewed at https://sportsperspectives.com/2017/11/15/redx-pharma-plc-redx-insider-iain-ross-purchases-348000-shares.html.
Redx Pharma PLC Company Profile
Redx Pharma Plc, formerly Redx Pharma Ltd, is engaged in drug discovery, pre-clinical development and licensing. The Company is engaged in drug discovery across cancer, infection and autoimmune diseases. The Company has over two programs in its oncology research activity, Smoothened Hedgehog (SMO) and Bruton’s Tyrosine Kinase (BTK), which has reached candidate nomination stage.
Receive News & Ratings for Redx Pharma PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Redx Pharma PLC and related companies with MarketBeat.com's FREE daily email newsletter.